Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
NUAK2 is a critical YAP target in liver cancer
Wei Chien Yuan
, Brian Pepe-Mooney
, Giorgio G. Galli
, Michael T. Dill
, Hai Tsang Huang
, Mingfeng Hao
, Yumeng Wang
, Han Liang
, Raffaele A. Calogero
, Fernando D. Camargo
Research output
:
Contribution to journal
›
Article
›
peer-review
117
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'NUAK2 is a critical YAP target in liver cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Liver Cancer
100%
NUAK2
100%
Cancer Cell Proliferation
20%
Malignancy
20%
Overgrowth
20%
Human Cancer
20%
Tumorigenesis
20%
Liver
20%
Cancer Cell Lines
20%
Actin Polymerization
20%
Feedback Loop
20%
Downstream Effectors
20%
Hippo Pathway
20%
Cell Fate
20%
Actionable Target
20%
Proliferation Apoptosis
20%
Transcriptional Targets
20%
Pharmacological Inactivation
20%
YAP Activation
20%
Growth Phenotype
20%
Actin-myosin
20%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Cell Proliferation
50%
Carcinogenesis
50%
Actin Polymerization
50%
Mediator
50%
Cell Fate
50%
Myosin
50%
Programmed Cell Death
50%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Liver Cancer
100%
Carcinogenesis
33%
Actin
33%
Hepatomegaly
33%